Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
1.
Proc Natl Acad Sci U S A ; 119(32): e2203121119, 2022 08 09.
Artículo en Inglés | MEDLINE | ID: mdl-35914124

RESUMEN

Animals maintain the ability to survive and reproduce by acclimating to environmental temperatures. We showed here that Caenorhabditis elegans exhibited temperature acclimation plasticity, which was regulated by a head-tail-head neural circuitry coupled with gut fat storage. After experiencing cold, C. elegans individuals memorized the experience and were prepared against subsequent cold stimuli. The cyclic adenosine monophosphate (cAMP) response element-binding protein (CREB) regulated temperature acclimation in the ASJ thermosensory neurons and RMG head interneurons, where it modulated ASJ thermosensitivity in response to past cultivation temperature. The PVQ tail interneurons mediated the communication between ASJ and RMG via glutamatergic signaling. Temperature acclimation occurred via gut fat storage regulation by the triglyceride lipase ATGL-1, which was activated by a neuropeptide, FLP-7, downstream of CREB. Thus, a head-tail-head neural circuit coordinated with gut fat influenced experience-dependent temperature acclimation.


Asunto(s)
Aclimatación , Tejido Adiposo , Caenorhabditis elegans , Frío , Sistema Digestivo , Cabeza , Vías Nerviosas , Cola (estructura animal) , Aclimatación/fisiología , Tejido Adiposo/metabolismo , Animales , Caenorhabditis elegans/anatomía & histología , Caenorhabditis elegans/fisiología , Proteínas de Caenorhabditis elegans/metabolismo , Proteína de Unión a Elemento de Respuesta al AMP Cíclico/metabolismo , Sistema Digestivo/metabolismo , Ácido Glutámico/metabolismo , Cabeza/inervación , Interneuronas/metabolismo , Lipasa/metabolismo , Neuropéptidos/metabolismo , Cola (estructura animal)/inervación , Sensación Térmica
2.
BMC Nephrol ; 25(1): 134, 2024 Apr 15.
Artículo en Inglés | MEDLINE | ID: mdl-38622507

RESUMEN

BACKGROUND: In the post-marketing stage, cases of hypocalcemia associated with bisphosphonate preparations (BPs) have been reported in patients with decreased kidney function, despite warning against use of BPs in such patients in the package insert (PI) of Japan. The purpose of this study was to investigate the safety of BPs in patients with decreased kidney function. METHODS: The cohort study was conducted in patients with osteoporosis and newly prescribed bisphosphonate utilizing real-world data from MID-NET® in Japan. The adjusted hazard ratios (aHRs) for hypocalcemia (a corrected serum Ca level < 8.00 mg/dL) relative to the normal group were calculated in each decreased kidney function group (mild, moderate or severe group). RESULTS: A total of 14,551 patients were included in the analysis, comprising 2,601 (17.88%) with normal (eGFR ≥ 90 mL/min/1.73m2), 7,613 (52.32%) with mild (60 ≤ eGFR < 90 mL/min/1.73m2), 3,919 (26.93%) with moderate (30 ≤ eGFR < 60 mL/min/1.73m2), and 418 (2.87%) with severe kidney function (eGFR < 30 mL/min/1.73m2). The aHRs (95% confidence interval) for hypocalcemia were 1.85 (0.75-4.57), 2.30 (0.86-6.21), and 22.74 (8.37-61.78) in the mild, moderate, and severe groups, respectively. The increased risk of hypocalcemia depending on kidney function was also observed even when calculating the aHR for each specific BP such as alendronate sodium hydrate, minodronic acid hydrate, and sodium risedronate hydrate. Furthermore, similar results were obtained in the sensitivity analysis by altering the outcome definition to a 20% or more reduction in corrected serum Ca level from the baseline, as well as when focusing on patients with more than one laboratory test result per 30 days during the follow-up period. CONCLUSIONS: These findings suggest that the risk of hypocalcemia during BP prescription is higher in patients with decreased kidney function, particularly those with severely decreased kidney function. The quantitative real-world evidence on the safety risk of BPs obtained in this study has led to the PI revision describing a relationship between hypocalcemia risk and decreased kidney function as a regulatory action in Japan and will contribute to promoting the proper use of BPs with appropriate risk management in clinical practice.


Asunto(s)
Hipocalcemia , Humanos , Estudios de Cohortes , Hipocalcemia/inducido químicamente , Hipocalcemia/epidemiología , Japón/epidemiología , Difosfonatos/efectos adversos , Riñón
3.
Proc Jpn Acad Ser B Phys Biol Sci ; 98(3): 126-139, 2022.
Artículo en Inglés | MEDLINE | ID: mdl-35283408

RESUMEN

Many organisms can survive and proliferate in changing environmental temperatures. Here, we introduce a molecular physiological mechanism for cold tolerance and acclimation of the nematode Caenorhabditis elegans on the basis of previous reports and a new result. Three types of thermosensory neurons located in the head, ASJ, ASG, and ADL, regulate cold tolerance and acclimation. In ASJ, components of the light-signaling pathway are involved in thermosensation. In ASG, mechanoreceptor DEG-1 acts as thermoreceptor. In ADL, transient receptor potential channels are thermoreceptors; however, the presence of an additional unidentified thermoreceptor is also speculated. ADL thermoresponsivity is modulated by oxygen sensory signaling from URX oxygen sensory neurons via hub interneurons. ASJ releases insulin and steroid hormones that are received by the intestine, which results in lipid composition changing with cold tolerance. Additionally, the intestinal transcriptional alteration affects sperm functions, which in turn affects the thermosensitivity of ASJ; thus, the neuron-intestine-sperm-neuron tissue circuit is essential for cold tolerance.


Asunto(s)
Aclimatación , Caenorhabditis elegans , Aclimatación/fisiología , Animales , Frío , Células Receptoras Sensoriales/metabolismo , Transducción de Señal
4.
Int J Med Sci ; 13(1): 48-59, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-26816494

RESUMEN

PURPOSE: Voltage-gated sodium channels (VGSCs) are drug targets for the treatment of epilepsy. Recently, a decreased risk of cancer associated with sodium channel-blocking antiepileptic drugs (AEDs) has become a research focus of interest. The purpose of this study was to test the hypothesis that the use of sodium channel-blocking AEDs are inversely associated with cancer, using different methodologies, algorithms, and databases. METHODS: A total of 65,146,507 drug-reaction pairs from the first quarter of 2004 through the end of 2013 were downloaded from the US Food and Drug Administration Adverse Event Reporting System. The reporting odds ratio (ROR) and information component (IC) were used to detect an inverse association between AEDs and cancer. Upper limits of the 95% confidence interval (CI) of < 1 and < 0 for the ROR and IC, respectively, signified inverse associations. Furthermore, using a claims database, which contains 3 million insured persons, an event sequence symmetry analysis (ESSA) was performed to identify an inverse association between AEDs and cancer over the period of January 2005 to May 2014. The upper limit of the 95% CI of adjusted sequence ratio (ASR) < 1 signified an inverse association. RESULTS: In the FAERS database analyses, significant inverse associations were found between sodium channel-blocking AEDs and individual cancers. In the claims database analyses, sodium channel-blocking AED use was inversely associated with diagnoses of colorectal cancer, lung cancer, gastric cancer, and hematological malignancies, with ASRs of 0.72 (95% CI: 0.60 - 0.86), 0.65 (0.51 - 0.81), 0.80 (0.65 - 0.98), and 0.50 (0.37 - 0.66), respectively. Positive associations between sodium channel-blocking AEDs and cancer were not found in the study. CONCLUSION: Multi-methodological approaches using different methodologies, algorithms, and databases suggest that sodium channel-blocking AED use is inversely associated with colorectal cancer, lung cancer, gastric cancer, and hematological malignancies.


Asunto(s)
Anticonvulsivantes/efectos adversos , Efectos Colaterales y Reacciones Adversas Relacionados con Medicamentos/epidemiología , Neoplasias/epidemiología , Bloqueadores de los Canales de Sodio/efectos adversos , Anticonvulsivantes/uso terapéutico , Minería de Datos , Epilepsia/complicaciones , Epilepsia/tratamiento farmacológico , Humanos , Neoplasias/tratamiento farmacológico , Bloqueadores de los Canales de Sodio/uso terapéutico , Estados Unidos , United States Food and Drug Administration
5.
J Microorg Control ; 28(3): 117-122, 2023.
Artículo en Inglés | MEDLINE | ID: mdl-37866893

RESUMEN

Previous studies in our lab have shown that peptidoglycan (PG) enhances the photocatalytic bactericidal effect. Therefore, in this study, we focused on the PG-constituting components. The PG-constituting components were added to Mesoplasma florum with no cell wall, respectively, and their effects on photocatalytic sterilization were investigated. The PG-constituting components used were amino sugars, amino acids, L-Alanine-D-Glutamic Acid (L-Ala-D-Glu) dipeptide of diaminopimelic acid (DAP)-type crosslinking peptide, and Lysine (Lys)-type crosslinking peptide. We compared the survival rates of M. florum cells and PG-constituting components-added M. florum cells after 3 h of photocatalytic reaction. Consequently, the survival rates of the cells that were added N-acetylglucosamine (GlcNAc), DAP, and L-Ala- D-Glu dipeptide were significantly lower than those of only the cells. Furthermore, the amounts of hydrogen peroxide (H2O2) generated by the photocatalytic reaction under the presence of these components were determined. The results showed that DAP, L-Ala- D-Glu dipeptide, and PG of DAP-type significantly increased the amount of H2O2 produced. From the above results, it is suggested that the presence of DAP and L-Ala- D-Glu dipeptide in the photocatalytic reaction boosts the production of H2O2 and enhances the bactericidal effect and that GlcNAc might produce reactive oxygen species other than H2O2.


Asunto(s)
Peróxido de Hidrógeno , Peptidoglicano , Peróxido de Hidrógeno/farmacología , Aminoácidos , Antibacterianos/farmacología , Alanina , Dipéptidos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA